NuCana (NCNA) Non-Current Assets (2016 - 2025)
NuCana's (NCNA) quarterly Non-Current Assets came in at $4.0 million in Q4 2025, up 22.8% year-on-year from $3.2 million in Q4 2024, and up 18.32% quarter-over-quarter from $3.3 million in Q3 2025.
NuCana (NCNA) Non-Current Assets (2016 - 2025) Analysis & Trends
NuCana has disclosed Non-Current Assets across 10 years of filings, most recently posting $4.0 million for Q4 2025.
- Non-Current Assets for Q4 2025 came in at $4.0 million, up 22.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.0 million (up 22.8% YoY), and the FY2025 annual result was $3.9 million, up 22.22% from the prior year.
- Non-Current Assets came in at $4.0 million for Q4 2025 at NuCana, up from $3.3 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $11.7 million in Q3 2021 to a low of $3.1 million in Q1 2025.
- The 5-year median for Non-Current Assets is $4.0 million (2023), against an average of $5.3 million.
- Across the five-year window, Non-Current Assets soared 50.99% in 2021 and slumped 50.5% in 2022, its largest moves.
- NuCana's Non-Current Assets stood at $7.9 million in 2021, then plunged by 50.5% to $3.9 million in 2022, then retreated by 11.39% to $3.5 million in 2023, then decreased by 7.07% to $3.2 million in 2024, then advanced by 22.8% to $4.0 million in 2025.
- The last three Non-Current Assets figures came in at $4.0 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | 62,953.78 |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | 4.56 Mn |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 486.60 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 30.30 Mn |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | 5.18 Mn |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 14.75 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | 39.71 Mn |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - | 3.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 3.32 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.22 Mn |
| Sep 30, 2024 | 3.45 Mn |
| Jun 30, 2024 | 3.44 Mn |
| Mar 31, 2024 | 3.49 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 4.21 Mn |
| Jun 30, 2023 | 4.21 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.91 Mn |
| Sep 30, 2022 | 7.34 Mn |
| Jun 30, 2022 | 7.26 Mn |
| Mar 31, 2022 | 7.86 Mn |
| Dec 31, 2021 | 7.90 Mn |
| Sep 30, 2021 | 11.69 Mn |
| Jun 30, 2021 | 8.23 Mn |
| Mar 31, 2021 | 8.14 Mn |